🇺🇸 Hypromellose Eye Drop in United States
1 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 1
Most-reported reactions
- Urinary Tract Infection — 1 report (100%)
Other Ophthalmology approved in United States
Frequently asked questions
Is Hypromellose Eye Drop approved in United States?
Hypromellose Eye Drop does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Hypromellose Eye Drop in United States?
Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. is the originator. The local marketing authorisation holder may differ — check the official source linked above.